Table 4.
Subgroup Analyses According to Age Group and Charson Comorbidity Index
| Multivariable Model | ||
|---|---|---|
| Variable | Hazard Ratio (95% CI) | P Value |
| Age: 20–39 y (n = 121 707, mortality = 219) | ||
| COVID-19 (vs control) | 0.38 (0.05–2.74) | .339 |
| Age: 40–59 y (n = 102 102, mortality = 1362) | ||
| COVID-19 (vs control) | 1.14 (0.72–1.81) | .562 |
| Age ≥60 y (n = 104 564, mortality = 9985) | ||
| COVID-19 (vs control) | 2.32 (2.03–2.65) | <.001 |
| Charson comorbidity index: 0–2 (n = 171 035, mortality = 1297) | ||
| COVID-19 (vs control) | 1.75 (1.25–2.45) | .001 |
| Charson comorbidity index ≥3 (n = 157 338, mortality = 10 269) | ||
| COVID-19 (vs control) | 2.16 (1.88–2.48) | <.001 |
Abbreviation: COVID-19, coronavirus disease 2019.